Drug Side Effects
Search
HEPATIC CANCER STAGE II
HEPATIC CANCER STAGE II
was reported 394 times
HEPATIC CANCER STAGE II is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-17A Antagonist [EPC]
1
0.0000
1
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
0.0000
2
GLP-1 Receptor Agonist [EPC]
1
0.0000
3
Tumor Necrosis Factor Blocker [EPC]
1
0.0000